A new benefit-based copay system calculates individualized copays based on clinical benefits and risk groups, aiming to increase adherence and reduce financial barriers. The approach could lead to lower copays for sickest patients and make prescription drug coverage more accessible.
Francisco Valero-Cuevas is awarded a research grant to study the biomechanics of the human thumb, aiming to improve surgical procedures for hand injuries. He will use cadaver hands and a dynamometer to measure the force of the thumb in various directions.
A large study reveals nearly 30% of participants were diagnosed with peripheral artery disease, a condition that affects millions in the US and Western Europe. Untreated PAD can lead to serious health consequences, including heart attack and stroke.
Scientists at Duke University have discovered a new enzyme that attaches aminoarabinose to the outer coat of gram-negative bacteria, reducing the ability of positively charged antibiotics to attach and kill them. This discovery offers a potential approach to overcoming antibiotic resistance.
Researchers have discovered a bacterial protein called anti-TRAP (AT) that participates in regulating tryptophan production. The newly discovered protein helps Bacillus bacteria control the production of tryptophan, one of the building blocks of most proteins in humans.
Researchers discovered that VEGF promotes the growth and survival of malignant tumor cells, affecting a wide range of cancers. The study found that inhibiting VEGF's effects can slow or halt tumor growth and is expected to improve treatment outcomes for some patients.
Researchers found that a new depression treatment approach, funded by NIMH, significantly reduces patient suffering and is cost-effective. The study's two-year data showed improved outcomes for patients receiving the intervention, which included training and resources for clinicians and medication or psychotherapy.